Collateral benefit: the comeback of MOG antibodies as a biomarker in neurological practice.
Department of Neurology, Medical Faculty, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany.
Orhan
O
Aktas
D001323:Autoantibodies / Q000097:blood*; D004673:Encephalomyelitis, Acute Disseminated / Q000175:diagnosis* / Q000276:immunology*; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D063308:Myelin-Oligodendrocyte Glycoprotein / Q000276:immunology*
D001323:Autoantibodies; C571326:MOG protein, human; D063308:Myelin-Oligodendrocyte Glycoprotein
MULTIPLE SCLEROSIS; NEUROIMMUNOLOGY; PAEDIATRIC NEUROLOGY